Jennifer Thulin, MD | |
67 Union Street, Suite 505, Natick, MA 01760 | |
(508) 651-3400 | |
Not Available |
Full Name | Jennifer Thulin |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 67 Union Street, Natick, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497825715 | NPI | - | NPPES |
706007 | Other | MA | TUFTS HEALTH PLAN |
6195318 | Medicaid | MA | |
2000000371 | Other | MA | HARVARD PILGRIM HEALTH |
J02299 | Other | BLUE SHIELD OF MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 51376 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jennifer Thulin, MD 67 Union Street, Suite 505, Natick, MA 01760 Ph: (508) 651-3400 | Jennifer Thulin, MD 67 Union Street, Suite 505, Natick, MA 01760 Ph: (508) 651-3400 |
News Archive
GlaxoSmithKline has announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and tolerability of the investigational GLP-1 (Glucagon-like peptide 1) agonist Syncria (albiglutide) in men and women with type 2 diabetes.
Cephalon, Inc. today announced that Risk Evaluation and Mitigation Strategies (REMS) for its medications NUVIGIL (armodafinil) Tablets [C-IV] and PROVIGIL (modafinil) Tablets [C-IV] have been approved by the U.S. Food and Drug Administration (FDA).
People who have biomarkers tied to inflammation in their blood in their 40s and 50s may have more brain shrinkage decades later than people without the biomarkers, according to a study published in the November 1, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The brain cell loss was found especially in areas of the brain that are affected by Alzheimer's disease.
GenoLogics, a leading provider of laboratory information management system (LIMS) software for next-generation genomics labs, today announced a detailed product roadmap for its eponymous LIMS, designed to provide the scalability, adaptability and usability features necessary for mainstream adoption of the most advanced sequencing technologies while supporting existing genotyping platforms.
Imaging epicardial adipose tissue, or the layer of fat around the heart, can provide extra information compared with standard diagnostic techniques such as coronary artery calcium scoring, according to research by cardiologists at Emory University School of Medicine.
› Verified 7 days ago